Complications of the association of Irritable and Post-cholecystectomy gut Syndromes: a case report
Keywords:Post-cholecystectomy Syndrome; Irritable Bowel Syndrome; Gastrointestinal tract.
Objective: Describe the main clinical findings of post-cholecystectomy syndrome and irritable bowel syndrome. Case Report: Post-cholecystectomy syndrome (SPC) is the term used to describe the persistence of biliary colic or abdominal pain in the upper right quadrant with a variety of gastrointestinal symptoms, similar to the characteristics experienced by an individual before cholecystectomy. These symptoms include intolerance to fatty foods, nausea, vomiting, heartburn, flatulence, indigestion, diarrhea, jaundice and intermittent episodes of abdominal pain. SPC can present itself in the postoperative period, as well as it can manifest months to years after the surgery. Irritable bowel syndrome (IBS) is a chronic functional disorder of the gastrointestinal tract characterized by recurrent abdominal pain and altered bowel habits, at least one day a week for three months with two or more of the following items: defecation, associated with a change in frequency of stools or associated with a change in the shape (appearance) of the stools, in the absence of an organic pathology. It is also known that the association of the two syndromes is a rare event, and biliary, extra-biliary and psychogenic causes should be investigated. Final Considerations: The purpose of this case report is to add information about the two syndromes.
Adilson, P., et al. Entendendo as razões para recusa da colecistectomia em indivíduos com colelitíase: Como ajuda-los em sua decisão? Arq Bra Cir Dig, 2014; 27, 114-119.
Arnaldo, L., P., & Celmo, C. P (2014). Semiologia Médica. Guanabara Koogan, (7a ed.).
Bader, H. S., et al. (2018).Clinical patterns of postcholecystectomy syndrome. Ann Hepatobiliary Pancreat Surg, 22, 52-57.
Caio, G. M., et al. (2017). Coledocolitíase: da suspeita ao diagnóstico. Arq Med Hosp Fac Cienc Med Santa Casa São Paulo, 62, 35-41.
Craig, N. (2020). Serotonin-norepinephrine reuptake inhibitors (SNRIs): Pharmacology, administration, and side effects. In: Lee S, UpToDate.
Drossman, D. A., et al. (2006). Rome III: the functional gastrointestinal disorders. VA: Degnon Associates, 49, 885-893.
Finlay, A. M. (2020). Overview of colon polyps. In: Lee S, UpToDate.
Hongbeom, K., et al. (2018). Postcholecystectomy syndrome: symptom clusters after laparoscopic cholecystectomy. Ann Surg Treat, 95:135-140.
Jaunoo, S. S., et al. (2010). Postcholecystectomy syndrome (PCS). Int J Surg, 8:15-17.
Jennifer, I., et al. (2019). A systematic review of the aetiology and management of post cholecystectomy syndrome. The Surgeon, 17:33-42.
José, S. S., et al. (2008). Colecistectomia: aspectos técnicos e indicações para o tratamento da litíase biliar e das neoplasias. Medicina- USP (Ribeirão Preto), 41:449-464.
Júlio, C. U. C., et al. (2009). Prevalência e fisiopatologia da litíase biliar em pacientes submetidos a transplante de órgãos. Arq Bra Cir Dig, 22:120-123.
Kok-Ann, G., et al. (2017). Irritable bowel syndrome in Asia: Pathogenesis, natural history, epidemiology, and management. J Gastroenterol Hepat, 33:99-110.
Madacsy, L., et al. (2015). Postcholecystectomy syndrome: from pathophysiology to differential diagnosis - a critical review. Pancreat Disord Ther, 5:162.
Maria, C. A. M., et al. (2009). Colecistite aguda: diagnóstico e tratamento. Rev Hosp Univer Pedro Ernesto, 8: 52-60.
Robert, M. (2018). Approach to minimal bright red bleeding per rectum. In: Lee S, UpToDate.
Turumin, J. L., et al. (2013). The role of the gallbladder in humans. Rev Gastroenterol Mex, 78:177-187.
William, D. C., et al. (2015). Irritable Bowel Syndrome: A Clinical Review. Cli Rev Edu, 313:949-958.
Zackria, R., & Waheed, A. (2020). Postcholecystectomy Syndrome.In: StatPearls. Treasure Island (FL): StatPearls Publishing.
How to Cite
Copyright (c) 2021 Amanda Sampaio Carrias; Ana Gabriela Freitas Borges; Luan Kelves Miranda de Souza
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.